Litigation Details for THERAPEUTICSMD, INC. v. AMNEAL PHARMACEUTICALS, INC. (D.N.J. 2020)
✉ Email this page to a colleague
THERAPEUTICSMD, INC. v. AMNEAL PHARMACEUTICALS, INC. (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-04-29 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-02-25 |
| Cause | 15:1126 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 10,052,386; 10,206,932; 8,633,178; 8,846,648; 8,846,649; 8,987,237; 8,993,548; 8,993,549; 9,006,222; 9,114,145; 9,114,146; 9,301,920 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in THERAPEUTICSMD, INC. v. AMNEAL PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Biologic Drugs cited in THERAPEUTICSMD, INC. v. AMNEAL PHARMACEUTICALS, INC.
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for THERAPEUTICSMD, INC. v. AMNEAL PHARMACEUTICALS, INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-04-29 | 1 | Complaint | 9,301,920 (the “’920 patent”); 10,052,386 (the “’386 patent”); and 10,206,932 (the “’932 patent”) (collectively…of United States Patent Nos. 8,633,178 (the “’178 patent”); 8,846,648 (the “’648 patent”); 8,846,649 (… (the “’649 patent”); 8,987,237 (the “’237 patent); 8,993,548 (the “’548 patent”); 8,993,549 (the “’549…’549 patent”); 9,006,222 (the “’222 patent”); 9,114,145 (the “’145 patent”); 9,114,146 (the “’146 patent… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C | External link to document |
| 2020-07-06 | 10 | Amended Complaint | 146 patent”); 9,301,920 (the “’920 patent”); 10,052,386 (the “’386 patent”); 10,206,932 (the “’932 patent…of United States Patent Nos. 8,633,178 (the “’178 patent”); 8,846,648 (the “’648 patent”); 8,846,649 …8,846,649 (the “’649 patent”); 8,987,237 (the “’237 patent); 8,993,548 (the “’548 patent”); 8,993,549 (the “… “’549 patent”); 9,006,222 (the “’222 patent”); 9,114,145 (the “’145 patent”); 9,114,146 (the “’146 …10,639,375 (the “’375 patent”); and 10,675,288 (the “’288 patent”) (collectively, “the patent(s)-in-suit”), | External link to document |
| 2021-12-09 | 45 | Order | ,006,222; 9,114,145; 9,114,146; 9,301,920; 10,052,386; 10,206,932; 10,639,375; 10,675,288; 10,806,740…this Consent Judgment, the term “Patents-in-Suit” shall mean U.S. Patent Nos. 8,633,178; 8,846,648; 8,…11,110,099. 4. Until expiration of the Patents-in-Suit, Amneal, including any of its successors… and assigns, is enjoined from infringing the Patents-in-Suit, on its own part or through any third …parties in connection with any infringement of the Patents-in-Suit by any such third parties in connection | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
